Related Experiment Videos

A rapid assay for cytotoxicity of unstimulated human monocytes

Insights

Dactinomycin (Act D) pretreatment enhances tumor cell susceptibility to lysis by human peripheral blood mononuclear cells. This study identifies monocytes as the key cytotoxic effector cells in this novel short-term assay.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Peripheral blood mononuclear cells (PBMCs) mediate cytotoxic responses.
  • Assessing monocyte-mediated cytotoxicity traditionally requires purification and longer assays.

Purpose of the Study:

  • To develop a short-term assay for analyzing monocyte cytotoxic function.
  • To investigate the role of monocytes in the lysis of dactinomycin-treated tumor cells.

Main Methods:

  • Wehi 164 fibrosarcoma cells were pretreated with dactinomycin (Act D).
  • Cytotoxicity assays using PBMCs were performed with 51Cr release.
  • Cell separation techniques (adherence, iron phagocytosis) and enzyme staining (naphthol AS acetate-esterase) were employed.

Main Results:

  • Act D pretreatment increased tumor cell lysis by PBMCs up to 60% (50-fold enhancement).
  • Cytotoxic effector cells were plastic-adherent, iron-phagocytic, and positive for naphthol AS acetate-esterase.
  • Depletion of phagocytic cells significantly reduced cytotoxicity.
  • Natural killer cell activity showed reciprocal behavior.

Conclusions:

  • The cytotoxic effector cells against Act D-treated Wehi 164 cells are monocytes.
  • This system provides a useful short-term assay for evaluating unstimulated monocyte cytotoxic function without prior purification.

Related Concept Videos